For US Healthcare Professionals Only

The interleukin-36 (IL-36) pathway plays an important role in inflammation leading to generalized pustular psoriasis (GPP). Discover the characteristics of IL-36 pathway activation and inhibition due to associated agonists and antagonists to stimulate or suppress an inflammatory response.

What you'll learn:

  • The consequences of IL-36 pathway dysfunction
  • Its significance on the inflammatory cascade and GPP
  • The impact of crosstalk between pathways on the inflammatory cascade and mutually reinforced disease in GPP-associated conditions
  • The inflammatory process through detailed illustrations
  • Triggers that initiate the inflammatory cascade that can lead to GPP

Access immunology disease state resources to support your knowledge and understanding of generalized pustular psoriasis (GPP).  

Understand the burden of GPP and how to make a differential diagnosis
An Update on Generalized Pustular Psoriasis – Article An Update on Generalized Pustular Psoriasis – Article

An Update on Generalized Pustular Psoriasis – Article
Patient-Case-Studies Patient-Case-Studies

GPP Patient Case Studies – PDF
Interactive-Disease-Education-Quiz Interactive-Disease-Education-Quiz

Quiz: Rare Skin Disease Round-Up – PDF
IL-36 Pustular Psoriasis-Factsheet IL-36 Pustular Psoriasis-Factsheet

Immune System Activation in Pustular Psoriasis vs Plaque Psoriasis – Factsheet
Learn about the disease pathway for GPP and IL‑36
The-Role-of-IL-36-in-Inflammation The-Role-of-IL-36-in-Inflammation
Play Button.png

The Role of IL-36 in Inflammation – Video
Role-of-IL-36-video1 Role-of-IL-36-video1
play-button

The Role of IL-36 in Generalized Pustular Psoriasis (GPP) – Video
IL-36 IL-36

Role of IL-36 in Pustular Skin Disease – Factsheet
Learn about the disease pathway for GPP and IL‑36 Learn about the disease pathway for GPP and IL‑36

The IL-36 Pathway and Generalized Pustular Psoriasis (GPP) – Infographic